Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection

Abstract Our systematic literature collection and annotation identified 106 chemical drugs and 31 antibodies effective against the infection of at least one human coronavirus (including SARS-CoV, SAR-CoV-2, and MERS-CoV) in vitro or in vivo in an experimental or clinical setting. A total of 163 drug...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yingtong Liu, Junguk Hur, Wallace K. B. Chan, Zhigang Wang, Jiangan Xie, Duxin Sun, Samuel Handelman, Jonathan Sexton, Hong Yu, Yongqun He
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/f088e050f20c4123afa354dfa35d4e8c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f088e050f20c4123afa354dfa35d4e8c
record_format dspace
spelling oai:doaj.org-article:f088e050f20c4123afa354dfa35d4e8c2021-12-02T14:02:34ZOntological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection10.1038/s41597-021-00799-w2052-4463https://doaj.org/article/f088e050f20c4123afa354dfa35d4e8c2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41597-021-00799-whttps://doaj.org/toc/2052-4463Abstract Our systematic literature collection and annotation identified 106 chemical drugs and 31 antibodies effective against the infection of at least one human coronavirus (including SARS-CoV, SAR-CoV-2, and MERS-CoV) in vitro or in vivo in an experimental or clinical setting. A total of 163 drug protein targets were identified, and 125 biological processes involving the drug targets were significantly enriched based on a Gene Ontology (GO) enrichment analysis. The Coronavirus Infectious Disease Ontology (CIDO) was used as an ontological platform to represent the anti-coronaviral drugs, chemical compounds, drug targets, biological processes, viruses, and the relations among these entities. In addition to new term generation, CIDO also adopted various terms from existing ontologies and developed new relations and axioms to semantically represent our annotated knowledge. The CIDO knowledgebase was systematically analyzed for scientific insights. To support rational drug design, a “Host-coronavirus interaction (HCI) checkpoint cocktail” strategy was proposed to interrupt the important checkpoints in the dynamic HCI network, and ontologies would greatly support the design process with interoperable knowledge representation and reasoning.Yingtong LiuJunguk HurWallace K. B. ChanZhigang WangJiangan XieDuxin SunSamuel HandelmanJonathan SextonHong YuYongqun HeNature PortfolioarticleScienceQENScientific Data, Vol 8, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Yingtong Liu
Junguk Hur
Wallace K. B. Chan
Zhigang Wang
Jiangan Xie
Duxin Sun
Samuel Handelman
Jonathan Sexton
Hong Yu
Yongqun He
Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection
description Abstract Our systematic literature collection and annotation identified 106 chemical drugs and 31 antibodies effective against the infection of at least one human coronavirus (including SARS-CoV, SAR-CoV-2, and MERS-CoV) in vitro or in vivo in an experimental or clinical setting. A total of 163 drug protein targets were identified, and 125 biological processes involving the drug targets were significantly enriched based on a Gene Ontology (GO) enrichment analysis. The Coronavirus Infectious Disease Ontology (CIDO) was used as an ontological platform to represent the anti-coronaviral drugs, chemical compounds, drug targets, biological processes, viruses, and the relations among these entities. In addition to new term generation, CIDO also adopted various terms from existing ontologies and developed new relations and axioms to semantically represent our annotated knowledge. The CIDO knowledgebase was systematically analyzed for scientific insights. To support rational drug design, a “Host-coronavirus interaction (HCI) checkpoint cocktail” strategy was proposed to interrupt the important checkpoints in the dynamic HCI network, and ontologies would greatly support the design process with interoperable knowledge representation and reasoning.
format article
author Yingtong Liu
Junguk Hur
Wallace K. B. Chan
Zhigang Wang
Jiangan Xie
Duxin Sun
Samuel Handelman
Jonathan Sexton
Hong Yu
Yongqun He
author_facet Yingtong Liu
Junguk Hur
Wallace K. B. Chan
Zhigang Wang
Jiangan Xie
Duxin Sun
Samuel Handelman
Jonathan Sexton
Hong Yu
Yongqun He
author_sort Yingtong Liu
title Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection
title_short Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection
title_full Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection
title_fullStr Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection
title_full_unstemmed Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection
title_sort ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/f088e050f20c4123afa354dfa35d4e8c
work_keys_str_mv AT yingtongliu ontologicalmodelingandanalysisofexperimentallyorclinicallyverifieddrugsagainstcoronavirusinfection
AT jungukhur ontologicalmodelingandanalysisofexperimentallyorclinicallyverifieddrugsagainstcoronavirusinfection
AT wallacekbchan ontologicalmodelingandanalysisofexperimentallyorclinicallyverifieddrugsagainstcoronavirusinfection
AT zhigangwang ontologicalmodelingandanalysisofexperimentallyorclinicallyverifieddrugsagainstcoronavirusinfection
AT jianganxie ontologicalmodelingandanalysisofexperimentallyorclinicallyverifieddrugsagainstcoronavirusinfection
AT duxinsun ontologicalmodelingandanalysisofexperimentallyorclinicallyverifieddrugsagainstcoronavirusinfection
AT samuelhandelman ontologicalmodelingandanalysisofexperimentallyorclinicallyverifieddrugsagainstcoronavirusinfection
AT jonathansexton ontologicalmodelingandanalysisofexperimentallyorclinicallyverifieddrugsagainstcoronavirusinfection
AT hongyu ontologicalmodelingandanalysisofexperimentallyorclinicallyverifieddrugsagainstcoronavirusinfection
AT yongqunhe ontologicalmodelingandanalysisofexperimentallyorclinicallyverifieddrugsagainstcoronavirusinfection
_version_ 1718392117633482752